A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) David MARKS, Marcos DE LIMA, Partow KEBRIAEI, Francesco LANZA, Christina CHO, Sergio GIRALT, Gizelle POPRADI, Michael HEMMER, Xin ZHANG, Richa SHAH, Verna WELCH, Erik VANDENDRIES, Matthias STELLJES, Wael SABER

Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin Wellington Fernandes da Silva, Gabriel Lacerda Marquez, Rafael Calil Salim, Vanderson Rocha

MINIMAL RESIDUAL DISEASE AND HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AP Azambuja